CRISPR Therapeutics
$5.04 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: $5.04 Billion

As of May 2023 CRISPR Therapeutics has a market cap of $5.04 Billion. This makes CRISPR Therapeutics the world's 2376th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2023

End of year Market Cap

Year Market cap Change
2023$5.04 B58.4%
2022$3.18 B-45.12%
2021$5.79 B-46.81%
2020$10.90 B194.5%
2019$3.70 B149.9%
2018$1.48 B56.74%
2017$0.94 B17.19%
2016$0.80 B

End of Day market cap according to different sources

On May 30th, 2023 the market cap of CRISPR Therapeutics was reported to be:

$5.10 Billion
by Yahoo Finance
$5.10 Billion
by CompaniesMarketCap
$5.10 Billion
by Nasdaq
$5.09 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$0.22 B-95.50%๐Ÿ‡บ๐Ÿ‡ธ USA